Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

SAN DIEGO, CA and TAICANG, China, May 07, 2024 -- Connect Biopharma Holdings Limited , a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic...

Related Keywords

San Diego ,California ,United States ,China ,San Diego Convention Center ,Taicang ,Hebei ,Tim Mccarthy ,Edward Kerwin ,Biopharma Holdings ,International Meeting ,Airway Inflammation ,Biopharma Holdings Limited Nasdaq ,International Conference ,Biopharma Holdings Limited ,Improved Lung Function ,Asthma Control Observed ,Moderate To Severe Uncontrolled Asthma ,Immune Response ,Upper Level ,Markets ,